Search


May 23, 20221 min read
Time to Evolve: Predicting engineered T cell toxicity with next gen. models
ART-TG contributed to this recent review by Donnadieu et al. in Journal for Immunotherapy of Cancer, https://jitc.bmj.com/content/10/5/e0...
50 views

Mar 16, 20221 min read
ART-TG recruits
ART-TG recruits engineers and managers for its projects. Please check the JOBS annoucements
54 views

Feb 21, 20221 min read
ASMA is laureate of BPI "Grand Défi - Biomédicaments"
ASMA project: Acoustic Solutions for Manufacturing Advanced Therapies
46 views



Oct 9, 20211 min read
Visitez l'ART-TG pour la fête de la science 2021
https://www.youtube.com/watch?v=6jzlHz2Vbrw
54 views


Jun 6, 20211 min read
Artificial Intelligence to improve the bioproduction of lentiviral gene therapy vectors.
ART-TG is pleased to announce its collaboration with WhiteLab Genomics on the development of artificial intelligence to improve the...
158 views


Mar 29, 20211 min read
ART-TG is a partner of the IRIS network of excellence (RHU) aiming to develop new generations...
. ..of gene therapies for severe immune deficiencies. In this consortium, ART-TG will bring its expertise on the quality control of...
84 views


Feb 2, 20211 min read
ART-TG joints the T2Evolve European consortium
Development of CAR-T cell therapies to fight cancer. Read the press release.
60 views

Jan 6, 20211 min read
ART-TG welcomes the arrival of Gaele RIGAULT
Gaele RIGAULT has been appointed to develop the partnerships and business of MAGENTA, the industrial integrator in cell and gene therapy.
64 views

Jan 5, 20211 min read
L'ART-TG vous présente ses meilleurs voeux pour 2021
Best wishes for a healthy new year 2021 and for the progress of science !
13 views


Oct 19, 20201 min read
Colloque Pharmacité
Organisé par le LEEM, 3 tables rondes font le point sur les partenariats public privé. Avec la participation d'A. Galy. Les échanges...
12 views

Sep 29, 20201 min read
HIV B-VAC project funded by ANRS
ART-TG and VRI teams have received 3-year funding from ANRS to develop new HIV vaccines based on CRISPR genome editing of B cells.
16 views

Sep 24, 20201 min read
MAGENTA reçoit le label "Intégrateur Industriel"
ART-TG et Cithera joignent leurs expertises en thérapie cellulaire et génique pour fonder MAGENTA qui reçoit le label "Integrateur...
70 views

Sep 9, 20201 min read
Presentation of ART-TG at the Mabdesign Symposium
ART-TG and MAGENTA are presented at the Bioproduction Congress organized by Mabdesign.
19 views